| [1] |
World Health Organization . WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
|
| [2] |
吴泰相, 李幼平, 姚巡 , 等. 实行临床试验注册制度,提高我国临床研究质量. 中国循证医学杂志, 2006,6(3):153-156.
|
| [3] |
Global Strategy for the Diagnosis, Management and Prevention of COPD. Global initiative for chronic obstructive lung disease(GOLD) 2019 report[EB/OL].[ 2018- 12- 22]. http:// www.goldcopd.org.
|
| [4] |
Raghu G, Remy-Jardin M, Myers JL , et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med, 2018,198(5):e44-e68.
doi: 10.1164/rccm.201807-1255ST
URL
|
| [5] |
徐飚, 成君 . 加强结核病实施性研究促进“终止结核病”目标实现. 中国防痨杂志, 2017,39(5):433-434.
|
| [6] |
李敏, 时景璞, 于慧会 . 真实世界研究与随机对照试验、单病例随机对照试验在临床治疗性研究中的关系比较. 中华流行病学杂志, 2012,33(3):342-345.
|
| [7] |
Bernard E, Lotte A . Clinical survey of the treatment of tuberculosis with streptomycin. Bull Int Union Tuberc, 1948,19(1):18-55.
|
| [8] |
Gler MT, Skripconoka V, Sanchez-Garavito E , et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med, 2012,366(23):2151-2160.
doi: 10.1056/NEJMoa1112433
URL
|
| [9] |
Pym AS, Diacon AH, Tang SJ , et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J, 2016,47(2):564-574.
doi: 10.1183/13993003.00724-2015
URL
|
| [10] |
Tupasi T, Gupta R, Danilovits M , et al. Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis. Bull World Health Organ, 2016,94(2):147-152.
doi: 10.2471/BLT.15.154997
URL
|
| [11] |
Sun F, Li Y, Chen Y , et al. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study. Eur Respir J, 2019, 53(3). pii: 1801770.
doi: 10.1183/13993003.01770-2018
URL
|
| [12] |
Tang S, Yao L, Hao X , et al. Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China. Clin Infect Dis, 2015,60(9):1361-1367.
|
| [13] |
沙巍, 张青, 崔文玉 , 等. 首次复治肺结核患者短程化疗新方案的临床研究. 中国防痨杂志, 2017,39(1):39-45.
|
| [14] |
刘晓清, 孙晓川 . 真实世界证据. 协和医学杂志, 2017,8(4/5):305-310.
|
| [15] |
明丹丹, 李军, 许璇 , 等. 真实世界研究的方法及其在临床研究中的应用. 中国药房, 2018,29(15):2138-2143.
|
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
